Skip to main content
. 2020 Jan 25;9(3):e014795. doi: 10.1161/JAHA.119.014795

Table 1.

Patient Characteristics (n=1645)

Total (n=1645) Low PRS (n=329) Average PRS (n=987) High PRS (n=329) P Value
Age, y 57 (50–64) 58 (51–64) 57 (51–64) 56 (49–63) 0.022
Male sex 799 (49%) 170 (52%) 518 (52%) 158 (48%) 0.37
Family history of CAD <60 y in first‐degree relative 601 (37%) 93 (28%) 358 (36%) 150 (46%) <0.001
Antihypertensive treatment 411 (25%) 83 (25%) 249 (25%) 79 (24%) 0.90
Lipid‐lowering treatment 384 (24%) 59 (18%) 236 (24%) 89 (28%) 0.015
Diabetes mellitus 94 (6%) 15 (5%) 59 (6%) 20 (6%) 0.60
Active smoking 266 (16%) 57 (17%) 156 (16%) 53 (16%) 0.82
Symptoms
Typical chest pain 89 (27%) 72 (22%) 291 (30%) 89 (27%) 0.005
Atypical chest pain 550 (34%) 115 (35%) 306 (31%) 129 (39%)
Nonanginal chest pain 293 (18%) 63 (19%) 189 (19%) 41 (13%)
Dyspnea 340 (21%) 76 (23%) 195 (20%) 69 (21%)
BMI, kg/m2 26.3 (23.8–29.4) 26.9 (24.3–29.6) 26.2 (23.7–29.3) 26.5 (23.7–29.5) 0.21
Total cholesterol, mmol/L 5.3 (4.7‐6.0) 5.2 (4.6–5.9) 5.3 (4.7–6.1) 5.3 (4.6–6.2) 0.17
HDL cholesterol, mmol/L 1.4 (1.1–1.7) 1.4 (1.2–1.7) 1.4 (1.1–1.7) 1.4 (1.1–1.7) 0.14
LDL cholesterol, mmol/L 3.3 (2.6–3.9) 3.1 (2.6–3.8) 3.3 (2.7–3.9) 3.4 (2.6–4.0) 0.055
Triglycerides, mmol/L 1.3 (1.0–2.0) 1.3 (0.9–1.9) 1.3 (1.0–2.0) 1.4 (1.0–2.2) 0.049
Creatinine, μmol/L 74 (65–85) 75 (65–85) 74 (65–85) 75 (66–85) 0.67

Data are presented as number (percentage) or median (interquartile range). Family history was missing in 6 patients, lipid‐lowering treatment was missing in 28 patients, diabetes mellitus was missing in 6 patients, smoking was missing in 7 patients, symptoms was missing in 10 patients, BMI was missing in 9 patients, total cholesterol was missing in 100 patients, HDL cholesterol was missing in 97 patients, LDL cholesterol was missing in 105 patients, triglycerides was missing in 109 patients, and creatinine was missing in 14 patients. BMI indicates body mass index; CAD, coronary artery disease; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein; PRS, polygenic risk score.